Medicare Obesity Policy Change Will Help Acomplia Launch, Sanofi Says
Executive Summary
Medicare's recent announcement about obesity coverage policies sends a positive signal for the upcoming launch of Sanofi-Synthelabo's Acomplia, the company said during a July 21 conference call
You may also be interested in...
Metabolic Syndrome Reimbursement Forecast: Outlook Remains Cloudy
In the near term, the best prospect for establishing a favorable reimbursement climate for metabolic syndrome may be to focus on treating comorbidities
Metabolic Syndrome Reimbursement Forecast: Outlook Remains Cloudy
In the near term, the best prospect for establishing a favorable reimbursement climate for metabolic syndrome may be to focus on treating comorbidities
Obesity Drugs May Be Covered Under Part D; CMS Invites Limits On Viagra
Drugs to treat "morbid obesity" may be covered by Medicare Part D plans despite the exclusion of "weight loss agents" from the program, CMS indicated in the final rules implementing the Medicare Rx benefit